FIELD: medicine. SUBSTANCE: method involves exposing a patient to preliminary external radiation at a dose of 10 Gr and next to it, administering metatrexate at endolymphatic non-regional application dose of 0.1 mg/kg of body mass. Regional application dose is administered into lymphatic vessels of foot back. Administration of cytostatic mixtures in loading doses and antioxidants in therapeutic doses is accompanied by repeated application of the procedure in cases of incomplete tumor resorption and with following daily irradiation at a single dose of 2 Gr of external radiation until the total dose of 26-36 Gr is achieved. EFFECT: enhanced effectiveness of treatment; eliminated metastases in lymphatic nodes; transformation of inoperable form into operable one.
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR APPLYING PROLONGED PHARMACOTHERAPY | 2003 |
|
RU2271833C2 |
METHOD FOR TREATING RELAPSES OF UTERINE CERVIX CANCER | 2003 |
|
RU2243766C1 |
THERAPY OF LOCALLY ADVANCED NONRESECTABLE RECTAL CANCER | 2007 |
|
RU2360712C1 |
METHOD FOR PREDICTING COMPLICATIONS OCCURRENCE IN PERFORMING ANTITUMOR TREATMENT | 1995 |
|
RU2107918C1 |
METHOD OF DETERMINATION OF ANTITUMORIGENIC THERAPY EFFECTIVENESS | 1991 |
|
RU2021620C1 |
METHOD FOR TREATING LOCAL RELAPSES OF UTERINE CERVICAL CANCER | 2003 |
|
RU2240114C1 |
METHOD FOR TREATMENT OF UTERUS CERVIX CANCER | 2004 |
|
RU2261706C1 |
METHOD FOR CONSERVATIVE TREATMENT IN PATIENTS AT NONOPERABLE PULMONARY CARCINOMA | 2005 |
|
RU2311185C2 |
METHOD OF INTRACAVITARY THERAPY IN TREATMENT OF PATIENTS WITH CANCER METASTASES INTO VAGINA | 2012 |
|
RU2478374C1 |
METHOD FOR DIAGNOSTICS OF CANCER RELAPSES AND METASTASES | 1993 |
|
RU2082984C1 |
Authors
Dates
2000-05-27—Published
1996-10-07—Filed